echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > [quick news] new features of Apple watch on September 17, 2018: take wearable devices into medical care

    [quick news] new features of Apple watch on September 17, 2018: take wearable devices into medical care

    • Last Update: 2018-09-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    New features of Apple Watch: this week, the apple watch series 4 entered the field of clinical medical devices In addition to the typical infrared sensors, the new wearable devices are equipped with ECG monitors When the application is opened and the fingers touch the crown, the electrodes placed on the back of the sapphire crystal and the crown side of the device will be used for portable ECG test Apple is becoming the first company to bring wearable devices into the medical field Currently, it has been approved by FDA to use sensors and applications to detect atrial fibrillation, but the device still needs to prove that there will not be a large number of false positives and send people to the emergency room Https://ාpage-3 the 2018 "truth seeking Award" was announced in Hefei on September 15 Jiang Lei, academician of the Chinese Academy of Sciences and researcher of the Institute of science and technology of the Chinese Academy of Sciences, was awarded the "outstanding scientist of truth seeking Award" Mr Cha Maosheng, chairman of Qiushi foundation, Mr Yang Zhenning, Mr Sun Jiadong, Mr Han Qide and Mr Shi Yigong attended the award ceremony In 2018, Hu Jiazhi, Tian Zhiyu and Wang Xiao of Peking University, Liu Jintao and Zhang Chao of Tsinghua University, Gao Jian and Zhu Shu of University of science and technology of China, Chen Gang of Fudan University, Zheng Hao of Shanghai Jiaotong University, Lu Yingying of Zhejiang University, Wan minping of South University of Science and technology and Gao Xiaofei of West Lake University were awarded the "outstanding young scholars Award" Young scholars, who have made outstanding achievements in the fields of new condensed theoretical physics, new energy materials, algebraic geometry, intestinal immunity and microorganisms Http://news.scienceet.cn/sbhtmlnews/2018/9/339164.shtm for more than 50 years, new antibiotics will eventually be able to fight against the most powerful "super bacteria" British journal Nature recently published a new discovery in Microbiology: scientists report that After chemical optimization, a class of natural products can become compounds with strong and broad-spectrum antibacterial activity against multi drug resistant gram-negative bacteria (such as E.coli) The latest research results of this in vitro experiment and mouse experiment can make this kind of compound become a new essential drug to fight against a serious threat to global health The research team of gene engineering technology company of the United States (Genentech) found a synthetic derivative named g0775, which has strong antibacterial activity against eskape pathogenic bacteria in vitro and can penetrate the bacterial outer membrane through an atypical mechanism in the process of searching for the derivatives with better target affinity and stronger outer membrane penetration Https:// more innovative drugs will move from RRC to Jiangnan Mid Autumn Festival in the world On the morning of September 16, the 9th China (Taizhou) International Pharmaceutical exposition was held One of the "highlights" at the opening ceremony was the exchange of memorandum of cooperation between ICGEB, CNCBD and CMC, the first regional research center of ICGEB in the world )"Hualuo" Taizhou China medicine city Zhang Xinmin, director of CNCBD, pointed out that "Mirs rise in the same wind and soar to 90000 Li in one day RRC will certainly make use of the east wind of the world's technological change, develop and grow, and contribute Chinese wisdom to the development of biotechnology and human health " Http://digitalpaper.stdaily.com/http_ HTM? Div = - 1 new virus related to kidney disease was found in animal experiments Researchers from Australia and the United States recently reported in the American Journal cell that they found a new virus related to kidney disease in mice, which is expected to provide new ideas for the treatment of chronic kidney disease and hereditary kidney disease in children In animal experiments, they found that some immune deficient mice die in middle age, far less than their life expectancy Further investigation showed that these mice died of renal failure The researchers then confirmed by DNA sequencing that the mouse's kidney failure was caused by a new parvovirus Parvovirus is a very small virus, which is usually benign if the immune system is healthy The parvovirus is highly specific for the kidneys "This new finding provides a new perspective for the study of viral nephropathy," lead author Ben ludig said in a press release Next researchers hope to use the virus's surface protein to develop gene therapy for children with hereditary kidney disease https://linkinghub.elsevier.com/retrieve/pii/S0092867418310298
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.